|
| 36599816 | Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data. | | 2023 |
| 37851634 | Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries. | | 2023 |
| 36960087 | On-demand, hospital-based, severe acute respiratory coronavirus virus 2 (SARS-CoV-2) genomic epidemiology to support nosocomial outbreak investigations: A prospective molecular epidemiology study. | | 2023 |
| 35293094 | Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment-limited individuals living with HIV. | HIV Med | 2022 |
| 36191692 | Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir. | Antiviral Res | 2022 |
| 34537474 | Impact of cobas PCR Media freezing on SARS-CoV-2 viral RNA integrity and whole genome sequencing analyses. | Diagnostic Microbiology and Infectious Disease | 2021 |
| 33635845 | Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda. | AIDS | 2021 |
| 34578305 | Validation of a Genotype-Independent Hepatitis C Virus Near-Whole Genome Sequencing Assay. | Viruses | 2021 |
| 34452444 | SHARED: An International Collaboration to Unravel Hepatitis C Resistance. | Viruses | 2021 |
| 32605062 | Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping. | Viruses | 2020 |
| 32071061 | Discordance between Etravirine Phenotype and Genotype-Based Predicted Phenotype for Subtype C HIV-1 from First-Line Antiretroviral Therapy Failures in South Africa. | Antimicrobial Agents and Chemotherapy | 2020 |
| 32069328 | An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing. | PLoS Pathog | 2020 |
| 32005884 | Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing. | Sci Rep | 2020 |
| 32408754 | Treatment Experience and Repeat Pregnancy Impact the Effectiveness of Non-Nucleoside Reverse Transcription Inhibitor-Highly Active Antiretroviral Therapy for the Prevention of Mother to Child Transmission of Human Immunodeficiency Virus. | AIDS Research and Human Retroviruses | 2020 |
| 31617907 | Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance. | Journal of Antimicrobial Chemotherapy | 2020 |
| 32471096 | Are We Ready for NGS HIV Drug Resistance Testing? The Second "Winnipeg Consensus" Symposium. | Viruses | 2020 |
| 32490325 | Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance. | Hepatology Communications | 2020 |
| 32529243 | Human Immunodeficiency Virus Phylogenetics in the United States-and Elsewhere. | Journal of Infectious Diseases | 2020 |
| 32857765 | HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade. | PLoS ONE | 2020 |
| 32908977 | Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. | bioRxiv | 2020 |
| 30895202 | Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis. | Open Forum Infectious Diseases | 2019 |
| 31764109 | Narrowing down the causes of failure of tenofovir (only) for preexposure prophylaxis. | AIDS | 2019 |
| 31712570 | Phylogenetic surveillance of travel-related Zika virus infections through whole-genome sequencing methods. | Scientific Reports | 2019 |
| 30873953 | Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEP. | Antiviral Therapy | 2019 |
| 31280314 | A systematic review of the genetic mechanisms of dolutegravir resistance. | J Antimicrob Chemother | 2019 |
| 31407474 | Mitochondrial DNA somatic mutation burden and heteroplasmy are associated with chronological age, smoking, and HIV infection. | Aging Cell | 2019 |
| 29362671 | The global origins of resistance-associated variants in the non-structural proteins 5A and 5B of the hepatitis C virus. | Virus Evolution | 2018 |
| 28719060 | Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach. | Journal of Viral Hepatitis | 2018 |
| 28703491 | Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study. | HIV Medicine | 2018 |
| 28652115 | Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996-2016. | Clinical Microbiology and Infection | 2018 |
| 30305354 | Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity. | J Virol | 2018 |
| 30350345 | Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus. | J Int AIDS Soc | 2018 |
| 30010985 | Accumulation of Multiple Mutations In Vivo Confers Cross-Resistance to New and Existing Integrase Inhibitors. | Journal of Infectious Diseases | 2018 |
| 30048246 | Extensive host immune adaptation in a concentrated North American HIV epidemic. | AIDS | 2018 |
| 30236532 | Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens. | Antiviral Research | 2018 |
| 30185556 | Phylogenetic approach to recover integration dates of latent HIV sequences within-host. | Proceedings of the National Academy of Sciences of the United States of America | 2018 |
| 29985647 | Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013. | AIDS Patient Care and STDs | 2018 |
| 29566538 | Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa. | Antiviral Chemistry and Chemotherapy | 2018 |
| 29666450 | Novel HLA class I associations with HIV-1 control in a unique genetically admixed population. | Scientific Reports | 2018 |
| 29513131 | Dolutegravir with boosted darunavir treatment simplification for the transmitted HIV thymidine analog resistance in Manitoba, Canada. | International Journal of STD and AIDS | 2018 |
| 29246970 | Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency. | EMBO Mol Med | 2018 |
| 27865749 | In vitro functional assessment of natural HIV-1 group M Vpu sequences using a universal priming approach. | Journal of Virological Methods | 2017 |
| 28953322 | A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015. | Journal of the International AIDS Society | 2017 |
| 28639996 | Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa? | Journal of acquired immune deficiency syndromes (1999) | 2017 |
| 28375875 | Emergent drug resistance with integrase strand transfer inhibitor-based regimens. | AIDS | 2017 |
| 28937991 | Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada. | PLoS ONE | 2017 |
| 28753637 | Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation. | PLoS One | 2017 |
| 28797026 | Rapid Decrease in Peripheral Blood Mononucleated Cell Telomere Length After HIV Seroconversion, but Not HCV Seroconversion. | Journal of acquired immune deficiency syndromes (1999) | 2017 |
| 28796673 | Human Immunodeficiency Virus Viral Load Rebound Near Delivery in Previously Suppressed, Combination Antiretroviral Therapy-Treated Pregnant Women. | Obstetrics and Gynecology | 2017 |
| 28482025 | Patterns of Transmitted Drug Resistance and Virological Response to First-line Antiretroviral Treatment Among Human Immunodeficiency Virus-Infected People Who Use Illicit Drugs in a Canadian Setting. | Clinical Infectious Diseases | 2017 |